Please use this identifier to cite or link to this item:
Title: Treating HIV-Positive/Non-AIDS Patients for Community-Acquired Pneumonia with ART
Author: Cillóniz, Catia
Ielpo, Antonella
Torres Martí, Antoni
Keywords: Pneumònia adquirida a la comunitat
VIH (Virus)
Community-acquired pneumonia
HIV (Viruses)
Issue Date: 10-Sep-2018
Publisher: Springer Nature
Abstract: Purpose of Review: This article reviews the most recent publications on community-acquired pneumonia (CAP) in the HIV-infected population on antiretroviral therapy (ART), focusing on epidemiology, prognostic factors, etiology, and antimicrobial therapy. The data discussed here were mainly obtained from a non-systematic review using Medline and references from relevant articles. Recent Findings: CAP remains a major cause of morbidity and mortality among HIV-infected patients and incurs high health costs despite the introduction of ART. Summary: HIV-infected patients are generally known to be more susceptible to bacterial pneumonia. Streptococcus pneumoniae is the most frequently reported pathogen in HIV-infected patients on ART, who present a higher rate of bacteremia than non-HIV-infected patients. Several studies have also examined microbial etiology and prognostic factors of CAP in HIV-infected patients on ART. Despite the high rate of bacterial pneumonia in these patients, mortality rates are not higher than in patients without HIV infection.
Note: Versió postprint del document publicat a:
It is part of: Current Infectious Disease Reports, 2018, vol. 20, num. 46
Related resource:
ISSN: 1523-3847
Appears in Collections:Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Files in This Item:
File Description SizeFormat 
686788.pdf902.15 kBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.